Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus

被引:23
|
作者
González, C
Garcia-Berrocal, B
Herráez, O
Navajo, JA
González-Buitrago, JM
机构
[1] Hosp Univ Salamanca, Serv Bioquim, Lab Autoinmunidad, Salamanca, Spain
[2] Univ Salamanca, Dept Bioquim & Biol Mol, E-37008 Salamanca, Spain
关键词
ANA-positive patients; anti-chromatin antibodies; anti-dsDNA antibodies; anti-nucleosome antibodies; systemic lupus erythematosus (SLE);
D O I
10.1515/CCLM.2004.049
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Antinucleosome (antichromatin) antibodies play a key role in the pathogenesis of systemic lupus erythematosus (SLE). The objective of the present study was to determine the clinical significance of antinucleosome (antichromatin) antibodies, antidsDNA antibodies and antihistone antibodies in patients with SLE in relation to patients with positive nuclear antibodies and healthy controls. We measured antinucleosome (antichromatin) antibodies, antidsDNA antibodies and antihistone antibodies in 70 patients with SLE, 35 antinuclear antibody (ANA)positive subjects without autoimmune disease and 35 blood donors. All antibodies were determined by enzyme linked immunosorbent assay (ELISA). We obtained the receiver operating caracteristic (ROC) curve and the area under the curve (AUC) for each autoantibody. Likewise, we obtained the sensitivity, specificity and positive and negative likelihood ratios for each autoantibody. The highest AUC was obtained for antinucleosome (0.898) and the lowest AUC for a kit for antidsDNA (0.725). Stratification of the control group (ANApositive subjects without autoimmune disease and blood donors) produced significant changes in the AUCs; all AUCs decreased when ANApositive patients without autoimmune disease were considered as controls and all AUCs increased when blood donors were considered as controls. These effects were less marked in antidsDNA antibodies. We observed discrepancies between kits (antinucleosome and antichromatin and two for antidsDNA). The highest sensitivity for SLE was obtained for antinucleosome antibodies (86%) and the highest specificity was obtained for antidsDNA antibodies (90%). In conclusion, antinucleosome and antichromatin kits show different degrees of clinical accuracy due to the cutoff selected by the manufacturer. Once the kits with the best performance and the optimal cutoffs have been selected, antinucleosome antibodies and antidsDNA antibodies provide similar information in established SLE.
引用
收藏
页码:266 / 272
页数:7
相关论文
共 50 条
  • [1] Anti-nucleosome, anti-dsDNA and anti-histone autoantibodies reactivity in systemic lupus erythematosus.
    Herráez, O
    Garcia-Berrocal, B
    González, C
    Navajo, A
    González-Buitrago, JM
    CLINICAL CHEMISTRY, 2002, 48 (06) : A147 - A147
  • [2] Prevalence and clinical significance of anti-nucleosome, anti-histone and anti-dsDNA antibodies in systemic lupus erythematosus patients
    Ostanek, L.
    Brzosko, M.
    Fischer, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 354 - 354
  • [3] Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
    Shang, Xiaoying
    Ren, Lisheng
    Sun, Guirong
    Yu, Teng
    Yao, Yuan
    Wang, Lin
    Liu, Fenghai
    Zhang, Lijun
    He, Xiaqin
    Liu, Mingjun
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (02) : 407 - 418
  • [4] Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus
    Adel A. Shabana
    Atef E. El-Ghawet
    Shereen A. Machaly
    Ekbal M. Abu Hashim
    Basma A. El-Kady
    Reham Shaat
    Clinical Rheumatology, 2009, 28 : 673 - 678
  • [5] Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus
    Shabana, Adel A.
    El-Ghawet, Atef E.
    Machaly, Shereen A.
    Abu Hashim, Ekbal M.
    El-Kady, Basma A.
    Shaat, Reham
    CLINICAL RHEUMATOLOGY, 2009, 28 (06) : 673 - 678
  • [6] Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients
    de Jesus, Adriana Almeida
    Arruda Campos, Lucia Maria
    Liphaus, Bernadete Lourdes
    Carneiro-Sampaio, Magda
    Pitangueira Mangueira, Cristovao Luis
    Rosseto, Eliane Aparecida
    Almeida da Silva, Clovis Artur
    Scheinberg, Morton
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2012, 52 (06) : 971 - 981
  • [7] Anti-chromatin (anti-nucleosome) antibodies
    Gomez-Puerta, J. A.
    Burlingame, R. W.
    Cervera, R.
    LUPUS, 2006, 15 (07) : 408 - 411
  • [8] Clinical evaluation of anti-nucleosome antibodies and anti-chromatin antibodies in systemic lupus erythematosus (SLE).
    Garcia-Berrocal, B
    Herráez, O
    González, C
    Navajo, JA
    González-Buitrago, JM
    CLINICAL CHEMISTRY, 2002, 48 (06) : A147 - A148
  • [9] Anti-C1Q, Anti-Nucleosome and Anti-dsDNA Antibodies in Juvenile Systemic Lupus Erythematosus patients
    Jesus, Adriana Almeida
    Liphaus, Bernadete Lourdes
    Carneiro-Sampaio, Magda
    Campos, Lucia Mattei Arruda
    Rosseto, Eliane
    Sheinberg, Morton
    Mangueira, Cristovao Luis
    Siva, Clovis Almeida
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 446 - 446
  • [10] Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease
    Souza, A.
    da Silva, L. M.
    Oliveira, F. R.
    Roselino, A. M. F.
    Louzada-Junior, P.
    LUPUS, 2009, 18 (03) : 223 - 229